SNDX FY 2022 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

SNDXSyndax Pharmaceuticals, Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$152M

Net Income

-$149M

EPS (Diluted)

$-2.46

Cash Flow

Operating Cash Flow

-$134M

Free Cash Flow

-$134M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$497M

Total Liabilities

$30M

Stockholders' Equity

$467M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$140M	-100.0%
Gross Profit	$0	$140M	-100.0%
Operating Income	-$152M	$26M	-678.8%
Net Income	-$149M	$25M	-699.1%